Body Vision Medical raises new round led by BAC and Sprim to scale AI lung imaging
What's the deal? Body Vision Medical, an AI-powered intraoperative imaging company, has closed a new funding round co-led by US firm Business Asia Consultants (BAC)Dealroom has a profile for this one. Try Dealroom → and Singapore-based Sprim Global InvestmentsDealroom has a profile for this one. Try Dealroom →. The company builds navigation and imaging technology used to diagnose and treat early-stage lung diseases.
Why now? Demand is climbing as more countries roll out nationalised lung cancer screening programmes, according to the company. BAC president and chief executive officer Larry Kronick said the market continues to expand as those programmes launch.
What's the endgame? Body Vision aims to improve diagnostic yield during biopsies deep in the lung while keeping costs low. The technology is available in 46 countries through more than 20 distributors, according to Sprim.
The signal: As governments expand lung cancer screening, imaging startups that combine broad distribution with affordable pricing are positioned to reach more patients.
Read more: InfoMed News
Image credit: Pulmonary Pathology
